In the first year following diagnosis, we found increased cumulative incidence risk ratios in a number of outcomes including: - Any mental, behavioural, or neurodevelopmental disorder 1.96 (1.93 - 1.99) - Postpartum depression 2.70 (2.61 - 2.79) - Eating disorders 2.06 (1.85 - 2.89) - PTSD 1.77 (1.69 - 1.86) We also saw significantly increased risk in rare but serious outcomes such as: - Wernicke's encephalopathy 2.39 (1.25 - 4.56) - Puerperal psychosis 1.80 (1.48 - 2.20) Interestingly, cases of hyperemesis gravidarum with metabolic disturbance displayed a significantly lower risk of any depression and postpartum depression compared with those without metabolic disturbance
Garraud O, Hamzeh-Cognasse H, Cognasse F
Recommendations to Pharmacists Pharmacists should use a patient-centered approach and evaluate whether each individual patient would benefit from the addition of a GLP-1 RA as an alternative to thrice-daily prandial insulin injections
Hydroxocobalamin is a long-acting, highly bioavailable form of B12, making it a preferred choice for both clinical use and B12 deficiency correction
Our environment is lurking with free radicals and toxins so your body has to protect itself from these burdens
IV delivery does achieve higher peak plasma concentrations a bolus IV push puts a large quantity of glutathione into circulation at once